Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 3.1B | 2.1B | 2.2B |
Cost of revenue | 1.2B | 2.5B | 1.7B | 1.8B |
Gross profit | 281M | 645M | 416M | 444M |
Operating expense | ||||
Research & development | -3M | 145M | 89M | 103M |
Selling general and admin | 98M | 110M | 117M | 142M |
Other operating expenses | 6M | 8M | 9M | — |
Operating income | 180M | 382M | 201M | 199M |
Non operating interest income | ||||
Income | 7M | 5M | 5M | 6M |
Expense | 106M | 112M | 116M | 129M |
Other income expense | -33M | -221M | 27M | -76M |
Pretax income | 45M | 51M | 114M | -3M |
Tax provision | 1M | -73M | -3M | -22M |
Net income | 44M | 124M | 117M | 19M |
Basic EPS | 0.4 | — | 1.1 | 0.1 |
Diluted EPS | 0.4 | — | 1.1 | 0.1 |
Basic average shares | 111.8M | — | 111.6M | 110.7M |
Diluted average shares | 113.3M | — | 113.5M | 112.4M |
EBITDA | 246M | 525M | 300M | 313M |
Net income from continuing op. | 44M | 124M | 117M | 19M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |